Physician profile
Randolph E Thornton
NPI 1750352647
$3,673.17
in general payments reported to CMS, 2019-2025
27 companies · $613 in 2025
The $613 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2020: $174 · 2021: $367 · 2022: $675 · 2023: $577 · 2024: $662 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,851.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $446.49 | 2021-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Supernus Pharmaceuticals, INC. | $429.01 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $401.95 | 2019-2025 | Bexsero, Rotarix, Pediarix |
| Ironshore Pharmaceuticals INC. | $367.78 | 2019-2024 | Jornay Pm |
| Corium, LLC | $223.91 | 2021-2025 | Azstarys |
| Neos Therapeutics, LP | $200.54 | 2019-2022 | |
| Pfizer INC. | $200.50 | 2019-2024 | |
| Cranial Technologies, INC | $180.12 | 2021-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $162.02 | 2019-2022 | |
| Sobi, INC | $150.38 | 2019-2024 | |
| Tris Pharma INC | $132.31 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Alk-Abello, INC | $119.76 | 2025 | Neffy, Grastek, Odactra |
| Sanofi Pasteur INC. | $98.72 | 2021-2025 | |
| Seqirus USA INC | $98.01 | 2021-2025 | Flucelvax, Flucelvax Quadrivalent |
| Vertical Pharmaceuticals, LLC | $87.07 | 2019-2025 | Relexxii |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verrica Pharmaceuticals INC. | $73.31 | 2023-2025 | Ycanth |
| Rhodes Pharmaceuticals L.P. | $47.20 | 2019 | |
| Sanofi-Aventis U.S. LLC | $43.35 | 2025 | |
| Kaleo, INC. | $40.63 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $34.37 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $27.77 | 2025 | Jornay Pm |
| Genentech USA, INC. | $24.82 | 2019-2020 | |
| Abbott Laboratories | $23.12 | 2024 | Id Now Strep A 2 |
| Acadia Pharmaceuticals INC | $16.65 | 2023 | Daybue |
| Adlon Therapeutics L.P. | $15.97 | 2019 | |
| Phadia US INC. | $14.17 | 2024 | Immunocap |
| Hologic Sales and Service, LLC | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.